Sajulga, Annie Rose .
HRN: 03-75-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2025
CO-AMOXICLAV 625MG (TAB)
04/10/2025
04/15/2025
PO
1tab
Bid
Uti, Thickly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes